Martyn Jacobs
Stock Analyst at Bell Potter
(0.04)
# 4,585
Out of 4,600 analysts
190
Total ratings
17.1%
Success rate
-17.6%
Average return
Main Sectors:
Stocks Rated by Martyn Jacobs
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: VFY Vitrafy Life Sciences Limited | Maintained: Buy | $5.15 | $3.82 | +34.82% | 12 | Aug 5, 2026 | |
| ASX: EBR EBR Systems, Inc. | Maintained: Buy | $0.90 | $0.28 | +219.15% | 19 | Aug 3, 2026 | |
| ASX: ONE Oneview Healthcare PLC | Maintained: Buy | $0.45 → $0.42 | $0.17 | +151.50% | 10 | Jul 30, 2026 | |
| ASX: AYA Artrya Limited | Maintained: Buy | $6.10 | $4.52 | +34.96% | 4 | Jul 30, 2026 | |
| ASX: BIO Biome Australia Limited | Maintained: Buy | $0.75 | $0.29 | +163.16% | 19 | Jul 30, 2026 | |
| ASX: IPD ImpediMed Limited | Maintained: Buy | $0.01 | $0.01 | +100.00% | 15 | Jul 29, 2026 | |
| ASX: LDX Lumos Diagnostics Holdings Limited | Maintained: Buy | $0.25 | $0.13 | +100.00% | 3 | Jul 28, 2026 | |
| ASX: MVP Medical Developments International Limited | Maintained: Buy | $0.85 → $1.00 | $0.47 | +112.77% | 15 | Jul 26, 2026 | |
| ASX: MVF Monash IVF Group Limited | Maintained: Hold | $0.75 → $0.77 | $0.70 | +10.00% | 8 | Jul 21, 2026 | |
| ASX: EMV EMVision Medical Devices Ltd | Maintained: Buy | $3.15 | $1.55 | +103.23% | 9 | Jul 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28.75 | $22.19 | +29.59% | 5 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.80 | $2.22 | +71.56% | 7 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.55 → $0.45 | $0.23 | +100.00% | 4 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $1.05 → $0.75 | $0.20 | +284.62% | 15 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.12 | n/a | 11 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.012 | n/a | 2 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $3.50 | n/a | 12 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.063 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.018 | n/a | 7 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.10 | n/a | 4 | Oct 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.05 | n/a | 2 | Oct 31, 2022 |
Vitrafy Life Sciences Limited
Aug 5, 2026
Maintained: Buy
Price Target: $5.15
Current: $3.82
Upside: +34.82%
EBR Systems, Inc.
Aug 3, 2026
Maintained: Buy
Price Target: $0.90
Current: $0.28
Upside: +219.15%
Oneview Healthcare PLC
Jul 30, 2026
Maintained: Buy
Price Target: $0.45 → $0.42
Current: $0.17
Upside: +151.50%
Artrya Limited
Jul 30, 2026
Maintained: Buy
Price Target: $6.10
Current: $4.52
Upside: +34.96%
Biome Australia Limited
Jul 30, 2026
Maintained: Buy
Price Target: $0.75
Current: $0.29
Upside: +163.16%
ImpediMed Limited
Jul 29, 2026
Maintained: Buy
Price Target: $0.01
Current: $0.01
Upside: +100.00%
Lumos Diagnostics Holdings Limited
Jul 28, 2026
Maintained: Buy
Price Target: $0.25
Current: $0.13
Upside: +100.00%
Medical Developments International Limited
Jul 26, 2026
Maintained: Buy
Price Target: $0.85 → $1.00
Current: $0.47
Upside: +112.77%
Monash IVF Group Limited
Jul 21, 2026
Maintained: Hold
Price Target: $0.75 → $0.77
Current: $0.70
Upside: +10.00%
EMVision Medical Devices Ltd
Jul 16, 2026
Maintained: Buy
Price Target: $3.15
Current: $1.55
Upside: +103.23%
Jun 3, 2026
Maintained: Buy
Price Target: $28.75
Current: $22.19
Upside: +29.59%
Jun 3, 2026
Maintained: Buy
Price Target: $3.80
Current: $2.22
Upside: +71.56%
Jun 1, 2026
Maintained: Buy
Price Target: $0.55 → $0.45
Current: $0.23
Upside: +100.00%
May 27, 2026
Maintained: Buy
Price Target: $1.05 → $0.75
Current: $0.20
Upside: +284.62%
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.12
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.012
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $3.50
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.063
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.018
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.10
Upside: n/a
Oct 31, 2022
Rated: Hold
Price Target: n/a
Current: $0.05
Upside: n/a